Background illustration for clinical trials search

Paid Clinical Trials New York City

Discover 4,033 paid clinical trials in New York City, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

for
Squamous Cell Carcinoma of Head and Neck
Location: The Bronx NY, Philadelphia PA, Boston MA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18 - 70+

Code: NCT07219212

Phase1, Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New York NY, Philadelphia PA, Boston MA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT04590326

Phase1, Phase2, Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

for
Immune Thrombocytopenia
Location: The Bronx NY, New Haven CT, Boston MA, Fairfax VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07104565

Phase2, Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: New York NY, Boston MA, Washington D.C. DC, Fairfax VA,
Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07227168

Phase1, Recruiting

A Study of CRD3874-SI in People With Solid Tumors

for
Sarcoma, Merkel Cell Carcinoma
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06021626

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

for
Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)
Location: Brick NJ, Buffalo NY, Durham NC, Winston-Salem NC,
Sponsor: Vasa Therapeutics

Sex: All

Age: 50+

Code: NCT07219511

Phase1, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: New York NY, New Haven CT, Boston MA, Fairfax VA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase1, Phase2, Recruiting

An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results

for
BRCA1 Mutation, POLD1 Gene Mutation, CDKN2A Mutation,
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 25+

Code: NCT05420064

Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

for
Multiple Myeloma
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05623020

Phase3, Recruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

for
Atrial Fibrillation
Location: The Bronx NY, Lake Success NY, Winchester VA,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 22+

Code: NCT07227532

Recruiting

Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

for
Mucosal Melanoma
Location: New York NY, Harrison NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05384496

Phase2, Recruiting

Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing

for
Wounds and Injuries
Location: Valhalla NY, Washington D.C. DC, Louisville KY,
Sponsor: ULURU Inc.

Sex: All

Age: 18 - 65

Code: NCT05424354

Recruiting

Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCT

for
Feasibility and Acceptability, Prevention Childhood Obesity
Location: New Hyde Park NY
Sponsor: Northwell Health

Sex: Female

Age: 18+

Code: NCT07254065

Recruiting

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

for
Extensive-stage Small-cell Lung Cancer
Location: New York NY, White Plains NY, Fountain Hill PA,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712355

Phase3, Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

for
Cutaneous Squamous Cell Carcinoma,
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05859074

Phase1, Recruiting

TaVNS for Delirium

for
Delirium Treatment, Delirium
Location: Stony Brook NY
Sponsor: Stony Brook University

Sex: All

Age: 22+

Code: NCT07258082

Recruiting

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

for
Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma,
Location: New York NY, Uniondale NY, Montvale NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06057935

Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: New York NY, Paramus NJ, New Haven CT, West Reading PA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06742996

Phase3, Recruiting

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

for
Thyroid Carcinoma, Metastatic Thyroid Carcinoma
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT03647358

Phase1, Recruiting

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

for
Refractory Acute Myeloid Leukemia,
Location: New York NY, Rockville Centre NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1+

Code: NCT06017258

Phase1, Recruiting

New York City stands out as a location known for a diverse array of clinical trials, thanks to its extensive healthcare network and renowned medical research institutions. Leading centers such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, Mount Sinai Health System, and Weill Cornell Medicine are at the forefront of pioneering studies across various fields. The city's rich combination of cutting-edge research facilities and a diverse population enhances the scope and impact of clinical trials conducted here.

Why choose New York City for clinical trials?

New York City is an exceptional choice for participating in clinical trials, renowned for its innovative research environment and strong emphasis on groundbreaking medical advancements, with prestigious institutions such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, and Mount Sinai Health System at the forefront.

By participating in a clinical trial in New York City, you not only gain early access to cutting-edge treatments but also contribute to significant medical research that could shape future healthcare practices.

Common conditions studied in New York City

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New York City